연구
연구업적
최근 5년 연구업적 현황
| 연도 | 2025년 | 2024년 | 2023년 | 2022년 | 2021년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 196편 | 179편 | 173편 | 163편 | 184편 |
| 공동 | 132편 | 147편 | 120편 | 115편 | 136편 | |
| 합계 | 328편 | 326편 | 293편 | 278편 | 320편 | |
3835. Cortactin Facilitates Malignant Transformation of Dysplastic Cells in Gastric Cancer Development
Alexis A Guenther 1, Suyeon Ahn 2, Jimin Min 3, Changqing Zhang 2, Hyuk-Joon Lee 4, Han-Kwang Yang 4, Bong Hwan Sung 5, Alissa M Weaver 6, Eunyoung Choi 7
Cell Mol Gastroenterol Hepatol. 2025;19(6):101490.
Link
3834. The association between the circadian misalignment of serum cortisol acrophase and sleep end time with chemotherapy-induced peripheral neuropathy
Shin JS, Jung S, Won GH, Lee SH, Kim J, Jung S, Yeom CW, Lee KM, Son KL, Kim JI, Jeon SY, Lee HB, Spiegel D, Hahm BJ.
Chronobiol Int. 2025 Feb;42(2):259-269.
Link
3833. Pre-Treatment Perceived Social Support Is Associated With Chemotherapy-Induced Peripheral Neuropathy in Patients With Breast Cancer: A Longitudinal Study
Shin JS, Jung S, Won GH, Lee SH, Kim J, Jung S, Yeom CW, Lee KM, Son KL, Kim JI, Jeon SY, Lee HB, Hahm BJ.
Psychiatry Investig. 2025 Apr;22(4):424-434.
Link
3832. The Association Between Circadian Disruption in Core Body Temperature Rhythm and Post-Chemotherapy Sleep Disturbances in Breast Cancer Survivors
Shin JS, Jung S, Won GH, Lee SH, Kim J, Jung S, Yeom CW, Lee KM, Son KL, Kim JI, Jeon SY, Lee HB, Hahm BJ.
J Sleep Res. 2025 Apr 29:e70080.
Link
3831. Cooperation between oncogenic NRF2 and wild-type HRAS promotes progression of breast cancer
Kim SJ, Saeidi S, Cho NC, Lee HB, Han W, Kim KP, Surh YJ.
Cell Signal. 2025 Oct;134:111920.
Link
3830. A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials
Potter S, Avery K, Ahmed R, de Boniface J, Chatterjee S, Dodwell D, Dubsky P, Federmann J, Finestone S, Gnant M, Hlauschek D, Iwata H, Jiang MY, Kaidar-Person O, Lee HB, MacKenzie M, Meyn A, Poortmans P, Poulakaki F, Richardson AL, Sepulveda KA, Spillane AJ, Thompson AM, Werutsky G, Wittmann P, Wright JL, Zdenkowski N, Cowan K, McIntosh SA; PRECEDENT Study Group.
NPJ Breast Cancer. 2025 Oct 28;11(1):116.
Link
3829. Germline BRCA1/2 Mutation Prevalence in Unselected ER-Low/HER2-Negative Breast Cancer
Yoo JW, Byeon J, Park WK, Kim J, Lee HB, Ahn SG, Baek SH, Lee SM, Lee SK, Chae BJ, Yu J, Lee JE, Kim SW, Nam SJ, Lee H, Kim SW, Yoo TR, Ryu JM.
Ann Surg Oncol. 2025 Nov 14.
Link
3828. The Lucerne Toolbox 3: digital health and artificial intelligence to optimise the patient journey in early breast cancer-a multidisciplinary consensus
Pfob A, Pinker K, Vaz-Luis I, Di Meglio A, Cardoso MJ, Curigliano G, Gentilini OD, Gruber G, Hauser N, Heil J, Kaidar-Person O, Knauer M, Lee HB, Lee SB, Loi S, Mannhart M, Mastora S, Meattini I, Di Micco R, Noske A, Peccatori FA, Poulakaki F, Reinisch M, Rubio IT, Swanton C, Tausch C, Vrancken Peeters MJ, Yu JH, Weber WP, Zerbe N, Poortmans P, Denkert C, Mann R, Delaloge S, Dubsky P; Toolbox 3 Consortium.
Lancet Oncol. 2025 Dec;26(12):e694-e706.
Link
3827. Inhibiting EZH2 complements steroid effects in Duchenne muscular dystrophy.
Jeon EY, Kwak YJ, Kang HJ, Kim HB, Jin SY, Park SJ, Kim RG, Ko DY, Won JK, Cho AN, Jung IK, Lee CH, Park JB, Kim HY, Chae JH, and Choi MR
Science Advances. 2025, 11, eadr4443
Link
3826. Precancerous Cells Initiate Glioblastoma Evolution and Contribute to Intratumoral Heterogeneity
Kim, H.J., Kim, K.W., Cha, D.H., Yoo, J., Kim, E.H., Chang, J.H., Kang, S.G., Park, J.W., Kim, J.H., Lee, Y., Lim, E., Kim, Y., Kim, M.H., Li, X., Lee, J.H. & Lee, J.H.
Cancer Discov. 2025 Jul 3;15(7):1377-1391
Link